Cefdinir - Revision history

Danbot: Restore original dosing content alongside dynamic SMW tables

2026-03-20T02:38:43Z

Restore original dosing content alongside dynamic SMW tables

← Older revision		Revision as of 02:38, 20 March 2026
Line 7:		Line 7:

	==Adult Dosing==		==Adult Dosing==
			*600mg/d divided q12-24hrs for 10 days for [[CAP]], chronic [[bronchitis]], acute [[sinusitis]], [[strep pharyngitis]], [[cellulitis]]


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Cefdinir]] [[Has Population::Adult]]		{{#ask: [[Has DrugName::Cefdinir]] [[Has Population::Adult]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

	==Pediatric Dosing==		==Pediatric Dosing==
			*14mg/kg/d PO divided q12-24hrs x10 days, max of 600mg/day


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Cefdinir]] [[Has Population::Pediatric]]		{{#ask: [[Has DrugName::Cefdinir]] [[Has Population::Pediatric]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

2026-03-20T01:52:38Z

Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

@@ Line 7: / Line 7: @@
 ==Adult Dosing==
-*600mg/d divided q12-24hrs for 10 days for [[CAP]], chronic [[bronchitis]], acute [[sinusitis]], [[strep pharyngitis]], [[cellulitis]]
+===Indications by Disease===
 ==Pediatric Dosing==
-*14mg/kg/d PO divided q12-24hrs x10 days, max of 600mg/day
+===Indications by Disease===
 ==Special Populations==

2025-07-18T16:12:46Z

← Older revision		Revision as of 16:12, 18 July 2025
Line 1:		Line 1:
	==General==		==General==
	*Type: ~~Third~~ generation [[Is DrugClass::cephalosporin]]		*Type: [[Is Generation::3rd generation]] [[Is DrugClass::cephalosporin]]
	*Dosage Forms: capsule, oral suspension		*Dosage Forms: capsule, oral suspension
	*Dosage Strengths: capsule: 300mg; oral suspension: 125mg/5mL, 250mg/5mL		*Dosage Strengths: capsule: 300mg; oral suspension: 125mg/5mL, 250mg/5mL

2025-07-18T14:46:33Z

← Older revision		Revision as of 14:46, 18 July 2025
Line 1:		Line 1:
	==General==		==General==
	*Type: Third generation [[cephalosporin]]		*Type: Third generation [[Is DrugClass::cephalosporin]]
	*Dosage Forms: capsule, oral suspension		*Dosage Forms: capsule, oral suspension
	*Dosage Strengths: capsule: 300mg; oral suspension: 125mg/5mL, 250mg/5mL		*Dosage Strengths: capsule: 300mg; oral suspension: 125mg/5mL, 250mg/5mL

2021-02-21T01:21:18Z

Common

← Older revision		Revision as of 01:21, 21 February 2021
Line 28:		Line 28:
	===Common===		===Common===
	*Diarrhea		*Diarrhea
	*~~[http://genericpharmaceuticals.science/cefdinir-colored-stool/ Stool discoloration]~~ which is guiac negative and returns to normal color after cessation<ref>Graves R, Weaver SP. Cefdinir-associated "bloody stools" in an infant. J Am Board Fam Med. 2008;21(3):246-248. doi:10.3122/jabfm.2008.03.070242</ref>		*Bloody stools which are guiac negative and returns to normal color after cessation<ref>Graves R, Weaver SP. Cefdinir-associated "bloody stools" in an infant. J Am Board Fam Med. 2008;21(3):246-248. doi:10.3122/jabfm.2008.03.070242</ref>

	==Pharmacology==		==Pharmacology==

2021-02-21T01:20:40Z

Common

← Older revision		Revision as of 01:20, 21 February 2021
Line 28:		Line 28:
	===Common===		===Common===
	*Diarrhea		*Diarrhea
	*[http://genericpharmaceuticals.science/cefdinir-colored-stool/ Stool discoloration] which is guiac negative and returns to normal color after cessation		*[http://genericpharmaceuticals.science/cefdinir-colored-stool/ Stool discoloration] which is guiac negative and returns to normal color after cessation<ref>Graves R, Weaver SP. Cefdinir-associated "bloody stools" in an infant. J Am Board Fam Med. 2008;21(3):246-248. doi:10.3122/jabfm.2008.03.070242</ref>

	==Pharmacology==		==Pharmacology==

2019-09-19T21:48:23Z

← Older revision		Revision as of 21:48, 19 September 2019
Line 164:		Line 164:
	<references/>		<references/>

	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:ID]]

2018-04-20T22:25:45Z

Common

← Older revision		Revision as of 22:25, 20 April 2018
Line 27:		Line 27:

	===Common===		===Common===
			*Diarrhea
	*[http://genericpharmaceuticals.science/cefdinir-colored-stool/ Stool discoloration] which is guiac negative and returns to normal color after cessation		*[http://genericpharmaceuticals.science/cefdinir-colored-stool/ Stool discoloration] which is guiac negative and returns to normal color after cessation

2017-10-12T00:57:24Z

Pharmacology: added half life, metabolism, excretion, mechanism of action

← Older revision		Revision as of 00:57, 12 October 2017
Line 30:		Line 30:

	==Pharmacology==		==Pharmacology==
	*Half-life:		*Half-life: 100 min
	*Metabolism:		*Metabolism: Not appreciably metabolized
	*Excretion:		*Excretion: Urine (7-25% as unchanged drug)
	*Mechanism of Action:		*Mechanism of Action: Bactericidal, inhibits bacterial cell wall synthesis

	==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==		==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==

2017-10-12T00:55:35Z

General: edited dosage forms, strengths, routes of administration

← Older revision		Revision as of 00:55, 12 October 2017
Line 1:		Line 1:
	==General==		==General==
	*Type: Third generation [[cephalosporin]]		*Type: Third generation [[cephalosporin]]
	*Dosage Forms: 300mg oral ~~solid, 125~~/~~5ml susp~~, ~~250~~/~~5ml susp~~		*Dosage Forms: capsule, oral suspension
			*Dosage Strengths: capsule: 300mg; oral suspension: 125mg/5mL, 250mg/5mL
			*Routes of Administration: PO
	*Common Trade Names: Omnicef		*Common Trade Names: Omnicef